Figure 2.
The relationships between the overall survival time of ccRCC patients and CHD9 expression: 1.00 represents the patients with low cytoplasm CHD9 expression; 2.00 represents the patients with high cytoplasm CHD9 expression.
The relationships between the overall survival time of ccRCC patients and CHD9 expression: 1.00 represents the patients with low cytoplasm CHD9 expression; 2.00 represents the patients with high cytoplasm CHD9 expression.